Recently, the deleterious role of B1RBK in FSGS has been described, where the activation of this receptor was associated with the upregulation of fibrotic and pro-inflammatory cytokines, such as TGF-β and IL-1β. The gene discussed is TGFB1; the disease is focal segmental glomerulosclerosis.